Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Bram ten Cate being referenced
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
2009
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bram ten Cate | 239 | 46 | 105 | 153 | 8 | 356 | |
| L J Jarvis | 204 | 31 | 67 | 217 | 8 | 411 | |
| Nancy H. Jones | 161 | 23 | 73 | 222 | 8 | 399 | |
| Piet De Somer | 137 | 31 | 95 | 160 | 7 | 349 | |
| Cyril Honsik | 132 | 18 | 104 | 189 | 10 | 331 | |
| B Kayibanda | 256 | 52 | 59 | 72 | 5 | 383 | |
| Alice Callard | 325 | 52 | 120 | 53 | 5 | 406 | |
| StevenA. Rosenberg | 94 | 29 | 144 | 253 | 7 | 364 | |
| Kiyoshi Habu | 179 | 49 | 117 | 84 | 8 | 325 | |
| Aldo Gasparollo | 132 | 47 | 90 | 235 | 9 | 340 | |
| Christian Stähli | 230 | 26 | 40 | 88 | 8 | 364 |
All Works
Loading papers...